Premium
Red blood cell exchange to avoid intubating a COVID ‐19 positive patient with sickle cell disease?
Author(s) -
Allison David,
CampbellLee Sally,
Crane Jason,
Vidanovic Vladimir,
Webb Shaun,
Fraidenburg Dustin,
Hussain Faiz
Publication year - 2020
Publication title -
journal of clinical apheresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.697
H-Index - 46
eISSN - 1098-1101
pISSN - 0733-2459
DOI - 10.1002/jca.21809
Subject(s) - medicine , acute chest syndrome , pneumonia , covid-19 , disease , pandemic , intensive care medicine , complication , respiratory distress , middle east respiratory syndrome , respiratory disease , acute respiratory distress , hemoglobinopathy , sickle cell anemia , pediatrics , surgery , lung , infectious disease (medical specialty)
As the COVID‐19 pandemic continues to claim lives across the globe, insufficient data exists regarding the optimal treatment. It is well known that patients 55 years of age or older and patients with certain chronic diseases are at higher risk of severe illness, including acute respiratory distress syndrome and death. A potentially fatal pulmonary complication of sickle cell disease, acute chest syndrome, can be precipitated by acute infections, including respiratory viruses. We report the case of a patient with sickle cell disease (HbSC) who developed COVID‐19 pneumonia and acute chest syndrome who was treated with emergent red blood cell exchange in order to avoid endotracheal intubation.